In force Publication date 10 Apr 15
Pharmacological properties of inhaled beta2-agonists in athletes with special emphasis on Salmeterol and Terbutaline
Project Title: Pharmacological properties of inhaled beta2-agonists in athletes with special emphasis on Salmeterol and Terbutaline
Researchers: Pr. V. Backer, Dr. M. Hostrup
Institution: Bispebjerg University Hospital, Denmark
Year accepted: 2013
Summary: The main objective of the present study is to help establish urinary thresholds for salmeterol and terbutaline on the prohibited list as done with salbutamol and formoterol. A secondary objective is to address how combined inhalation of beta2-agonists influences the excretion of each substance in the urine. Lastly, an objective is to investigate the relationship between the specific gravity of urine samples and the concentrations of each beta2-agonist
Available in 1 language.